Project Details
Description
Amyotrophic lateral sclerosis (ALS or Lou Gehrig’s Disease) is a fatal disease of motor neurons.
Mutations in the gene FUS cause familial and sporadic forms ALS, and FUS pathology is also
found in the related neurodegenerative disorder, frontotemporal dementia (FTD). In novel
animal and cellular models of ALS, this project will elucidate toxic gain-of-function mechanisms
by which mutant FUS causes motor neuron and frontotemporal degeneration. This effort will
test one promising approach to the treatment of FUS-ALS and FTD, and provide important
insights that will lead to the development of other novel therapies.
Status | Finished |
---|---|
Effective start/end date | 6/15/19 → 2/28/23 |
Funding
- National Institute of Neurological Disorders and Stroke: US$648,000.00
- National Institute of Neurological Disorders and Stroke: US$583,199.00
ASJC Scopus Subject Areas
- Clinical Neurology
- Neurology
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.